Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» gene editing
gene editing
Novartis plots Precision attack on sickle cell, paying $75M and putting up $1.4B in biobucks to form in vivo gene editing pact
Fierce Biotech
Wed, 06/22/22 - 10:23 am
Novartis
gene editing
Precision Biosciences
sickle cell disease
beta thalassemia
Precision hails phase 1/2 data as proof it could deliver the first approved off-the-shelf CAR-T
Fierce Biotech
Wed, 06/8/22 - 11:00 pm
Precision Biosciences
CAR-T
gene therapy
gene editing
non-Hodgkin lymphoma
Immatics and Editas join up to bring CRISPR to 'gamma delta' cell therapy
BioPharma Dive
Tue, 06/7/22 - 10:22 am
Editas Medicine
CRISPR
gene editing
Immatics
gamma delta cell therapy
Researchers develop CRISPR mechanism to edit multiple DNA sites at once
BioSpace
Fri, 05/20/22 - 10:50 am
Rice University
gene editing
CRISPR
drive and process arrays
Big Pharma partnerships, record $22.7B investment raise profile of regenerative medicine in 2021
Fierce Biotech
Tue, 04/5/22 - 11:41 pm
regenerative medicine
gene editing
gene therapy
Big Pharma
Intellia Therapeutics
2 gene editing biotechs team up to improve on delivery with $45 upfront
Fierce Biotech
Thu, 03/31/22 - 11:20 pm
gene editing
gene therapy
Myeloid Therapeutics
Prime Medicine
Drugs based on next-generation gene editing are moving toward the clinic faster than CRISPR 1.0
Stat
Thu, 02/10/22 - 10:25 am
CRISPR
gene editing
Jennifer Doudna
Intellia’s Rewrite Therapeutics buyout brings new precision to gene editing
MedCity News
Fri, 02/4/22 - 10:48 am
Intellia Therapeutics
Rewrite Therapeutics
gene editing
M&A
Sarepta reveals gene editing alliance with biotech exploring alternative delivery methods
BioPharma Dive
Tue, 02/1/22 - 11:18 pm
Sarepta Therapeutics
gene editing
gene therapy
GenEdit
Gene editing startup Metagenomi raises $175M to advance research pipeline
BioPharma Dive
Tue, 01/25/22 - 10:55 am
Metagenomi
Moderna Therapeutics
R&D
gene editing
funding
Why Pfizer's Deal With Beam Therapeutics Is a Smart Move
Motley Fool
Mon, 01/24/22 - 10:12 am
Pfizer
Beam Therapeutics
gene editing
Pfizer expands into gene editing with Beam research deal
BioPharma Dive
Mon, 01/10/22 - 11:30 am
Pfizer
Beam Therapeutics
MRNA
gene editing
First sickle cell patient treated with CRISPR gene-editing still thriving
NPR
Fri, 12/31/21 - 11:07 am
CRISPR
gene editing
sickle cell disease
CRISPR, ViaCyte beat Vertex to the clinic with diabetes cell therapy that evades the immune system
Endpoints
Tue, 11/16/21 - 10:34 am
CRISPR Therapeutics
ViaCyte
Vertex Pharmaceuticals
type 1 diabetes
cell therapy
gene editing
Using CRISPR to find a new drug target for multiple sclerosis, inflammatory bowel disease
Fierce Biotech
Sun, 11/14/21 - 10:52 pm
CRISPR
gene editing
Vanderbilt
multiple sclerosis
allergies
IBD
Exavir Aims CRISPR Program at HIV, Sees Powerful Preclinical Results
BioSpace
Wed, 11/10/21 - 10:47 am
HIV
Exavir Therapeutics
gene editing
CRISPR
Moderna finally cracks into gene editing with Metagenomi pact thanks to 'irresistible' data
Fierce Biotech
Tue, 11/2/21 - 10:46 am
Moderna Therapeutics
gene editing
CRISPR
Metagenomi
Intellia, LogicBio fuel hope for in vivo gene editing with new animal data in rare diseases: report
Fierce Biotech
Mon, 10/25/21 - 11:53 pm
Intellia Therapeutics
LogicBio Therapeutics
gene editing
NTLA-2001
ATTR amyloidosis
Intellia looks to eye diseases in latest deal
BioPharma Dive
Wed, 10/13/21 - 10:38 pm
Intellia Therapeutics
gene editing
eye disease
Editas' gene-editing data has company touting prime time based on early vision improvement signals but questions remain
Fierce Biotech
Wed, 09/29/21 - 11:12 am
CRISPR
Editas Medicine
gene editing
EDIT-101
vision loss
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »